Results 221 to 230 of about 42,609 (234)

Oseltamivir

Reactions Weekly
openaire   +2 more sources

Possible harms of oseltamivir—a call for urgent action

Lancet, The, 2009
Mark A Jones
exaly  

Intravenous zanamivir or oral oseltamivir for hospitalised patients with influenza: an international, randomised, double-blind, double-dummy, phase 3 trial.

The Lancet Respiratory Medicine, 2017
F. Marty, Joan Vidal-Puigserver, C. Clark, S. Gupta, E. Merino, D. Garot, M. Chapman, F. Jacobs, E. Rodríguez-Noriega, P. Husa, Denise D Shortino, Helen A. Watson, P. Yates, A. Peppercorn   +13 more
semanticscholar   +1 more source

Clinical Pharmacokinetics of the Prodrug Oseltamivir and its Active Metabolite Ro 64-0802

Clinical Pharmacokinetics, 2012
Penelope Ward
exaly  

Source of oseltamivir resistance due to single E119D and double E119D/H274Y mutations in pdm09H1N1 influenza neuraminidase

Journal of Computer-Aided Molecular Design, 2019
Chonnikan Hanpaibool, Matina Leelawiwat, Kaito Takahashi, T. Rungrotmongkol   +3 more
semanticscholar   +1 more source

Oseltamivir for influenza

Lancet, The, 2016
Peter Doshi, Carl Heneghan
exaly  

Oseltamivir Ring Prophylaxis for Containment of 2009 H1N1 Influenza Outbreaks

New England Journal of Medicine, 2010
Jonathan Yap, Alex R Cook, Mark I Chen
exaly  

Efficacy and safety of oseltamivir in treatment of acute influenza: a randomised controlled trial

Lancet, The, 2000
exaly  

Community Transmission of Oseltamivir-Resistant A(H1N1)pdm09 Influenza

New England Journal of Medicine, 2011
Aeron C Hurt, Yi-Mo Deng, Anne Kelso
exaly  

Oseltamivir for influenza – Authors' reply

Lancet, The, 2015
Arnold S Monto, Stuart J Pocock
exaly